During the next 30 days, MegaSporeBiotic, an all-spore probiotic, showed a 60% reduction in leaky gut markers in humans. This was in comparison to the control group, which only received a saline treatment. The study also found that MegaSporeBiotic, in combination with MegaPre, was more effective than MegaSporeBiotic alone. The results were also more consistent across the study donors.
What is Comparable to MegaSporeBiotic?
The study involved 80 participants with high triglycerides. They were randomly assigned to three groups. One group received MegaSporeBiotic, the other received a low-FODMAP diet, and the third group received a nutraceutical agent containing a probiotic and prebiotics.
The study was conducted in the Cleveland Clinic’s Department of Inflammation and Immunity. The study’s goal was to compare the effects of MegaSporeBiotic and a nutraceutical agent on two standard treatment regimens for IBS. Generally, standard treatment regimens for IBS include using a probiotic, a prebiotic, and vitamins. However, these regimens are not effective in most patients. Hence, a more effective and comprehensive regimen may be necessary.
The study’s results were published in the Journal of Parenteral and Enteral Nutrition. The researchers found that MegaSporeBiotic improved the immune markers in mice and improved the integrity of the intestinal barrier in mice with a DxS-induced colitis model. These findings may support MegaSporeBiotic’s use in the treatment of irritable bowel syndrome (IBS) and ulcerative colitis (UC).
The researchers also reported that MegaSporeBiotic could reduce inflammation in the acetic acid-induced colitis model in rats. It also showed a reduction in the total loss of colon bacteria from antibiotic treatment. The study showed that MegaSporeBiotic was more effective than a nutraceutical or low-FODMAP diet. However, it was not included in the metabolic health measures.
The study also showed that MegaSporeBiotic improved the immune system, up-regulated secretory IgA levels, and closed tight junctions between colonocytes. It also improved pattern recognition, increased circulating T and B lymphocytes, and had an effect on immune cells that were critical for the body’s natural defense against infections. The study also showed that MegaSporeBiotic helped heal the gut and increased the thickness of the intestinal mucosa. In addition, MegaSporeBiotic helped reduce symptoms of leaky gut syndrome in humans.
The researchers also observed that MegaSporeBiotic was more effective in treating IBS than standard treatment regimens for IBS. Standard treatment regimens for IBS include the use either of a lactobacillus strain or a prebiotic. However, most of these probiotics fail to provide consistent results.
Microbiome Labs’ flagship product is Megasporebiotic. Megasporebiotic is a probiotic that contains five spore-forming strains of Bacillus spp. Designed to provide long-term support to the microbiome, MegaSporeBiotic supports healthy gut barrier function and immune function. It also promotes microbial diversity, a key factor in maintaining a healthy digestive tract. This is the first all-spore probiotic on the market. MegaSporeBiotic is a safe, effective, and natural way to support a healthy microbiome. It is ideal for those with long-term gut health needs.
The study also found that MegaSporeBiotic reduced damage to the colonic mucosa in mice. This was in addition to its effect on the severity score and the rectal volume sensation test.